Skip to main content
Publish date:

Wednesday's Winners & Losers: Jabil Circuit

Shares fall 16% after the company gives guidance below expectations.
Author:

Electronics manufacturing services firm

Jabil Circuit

(JBL) - Get Jabil Inc. Report

fell $1.82, or 16%, to $9.56 after the company offered third-quarter guidance below Street expectations. Jabil forecast EPS, excluding charges, of between 18 cents and 22 cents on revenue of $3.05 billion to $3.15 billion. Analysts were expecting a profit of 33 cents a share on revenue of $3.25 billion. Jabil's stock was also downgraded by JP Morgan to underweight from overweight, by Credit Suisse to neutral from outperform and by Longbow Research to neutral from buy.

Amgen

(AMGN) - Get Amgen Inc. Report

gained 1.7% to $41.54 as investors prepare for a judge's decision regarding Roche's ability to market Mircera for chronic kidney disease. The drug could potentially compete with Amgen's Aranesp and Epogen in the U.S. pending the ruling.

Bear Stearns analyst Mark Schoenebaum said in a Wednesday note that he believes Amgen now reflects expectations that Mircera will launch. He believes the worst-case scenario could have Amgen's stock seeing 10% upside, while if Mircera doesn't launch the upside for Amgen could exceed 20%.

Rambus

(RMBS) - Get Rambus Inc. Report

shares were up $2.19, or 11.8%, to $20.80 as a federal jury debated a case filed by the company that

sought a royalty

for technology related to memory chips from

Micron

(MU) - Get Micron Technology, Inc. Report

,

TheStreet Recommends

Hynix Semiconductor

and

Nanya Technology

. Rambus' opponents are contending that the company misled them during discussions in the 1990s and did not disclose that it had sought patents on its technology that has since become part of the industry standard, according to a report in the

San Jose Mercury News

.

San Diego-based women's retailer

Charlotte Russe

(CHIC) - Get Global X MSCI China Communication Services ETF Report

fell 14.4% to $17.20. The company forecast third-quarter earnings per share between 27 cents and 30 cents. Analysts polled by Thomson Financial are looking for EPS of 41 cents.

PDL BioPharma

(PDLI) - Get PDL BioPharma, Inc. Report

rose 4.1% to $10.74 on no news.

Cooper Tire & Rubber

(CTB) - Get Cooper Tire & Rubber Company Report

, a Findlay, Ohio, maker and vendor of replacement tires, lost 10% to $15.53 on a KeyBanc Capital Markets downgrade to hold from aggressive buy.

This article was written by a staff member of TheStreet.com.